a platform offering fully automated preparation and reconsitution devices.
More aboutan all-in-one platform offering fully automated preparation and delivery devices
More aboutmodular solutions for airless spray device for topical treatment and delivery, adaptable for various drugs.
More abouta platform offering assisted and wireless injection of highly viscous products.
More aboutEVEON transforms the patient experience. We offer technological, digital and user innovation products and services to improve the handling, preparation (lyo, dilution, liquid-liquid,...) and administration (injection, infusion, spraying, nebulization,...) of specific drugs. Our native digital platform enables tracking and connected features beyond the core disposable fluidic features. We develop and manufacture custom product for pharmaceutical, biotech companies and medical device manufacturers from prototype to production under ISO-13485 standards.
In close collaboration with healthcare players, we provide smart and efficient solutions for all healthcare professionals, clinicians, nurses, surgeons, practitioners.
Read moreTransforming Patient Experience
Based on more than 7 years of research, EVEON is specialized in preparation and automatic delivery of therapeutic treatments to improve patients’ quality of life. Partner of healthcare players, EVEON designs and manufactures technological, digital and user innovation custom-made products and services.
Implanted at the heart of the French Silicon valley, EVEON is proud to have Grenoble INP and the French Alternative Energies and Atomic Energy Commission (CEA) among its privileged partners.
EVEON contributes to studies about feasibility of intratumoral delivery to induced glioblastoma, in a large animal model. EVEON developed the preclinical injection system for this project. Work on this subject has been published in the journal Plos One.
EVEON and Laboratoires Théa, European leader in the field of ophthalmology, announce their partnership in the development of innovative medical.
The project KinCellS, supported by the Auvergne Rhone Alpes region, as part of the call for R&D booster projects, was launched on September 9th, 2020, with the consortium members : Nanobiose, project leader, EVEON and the SyMMES laboratory.
Article OnDrugDelivery about the results of work carried out in joint efforts by EVEON and LMGP in the field of protein adsorption and aggregation, and how the results of this work have led to improvements in the design of EVEON’s proprietary micropump.
